| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000271738.1 |
Tanespimycin |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027084376 |
Resistant |
| ENSG00000271738.1 |
Tanespimycin |
Chronic Lymphocytic Leukemia |
0.040306056 |
Resistant |
| ENSG00000271738.1 |
Tanespimycin |
Brain lower grade glioma |
0.042625457 |
Resistant |
| ENSG00000271738.1 |
Tanespimycin |
Lung squamous cell carcinoma |
0.008143213 |
Resistant |
